CMS’ “Potential” NCD List Gets Stakeholder Support, But Questions Remain
This article was originally published in The Gray Sheet
Executive Summary
The device industry and other Medicare stakeholders are generally supportive of CMS' recent move to publicize topics it is considering for future national coverage determinations, though some worry that the agency will use the process to limit patient access to technologies